News tagged with cirrhosis
Cirrhosis patients losing muscle mass have a higher death rate
Medical researchers at the University of Alberta reviewed the medical records of more than 100 patients who had a liver scarring condition and discovered those who were losing muscle were more apt to die while waiting for ...
Feb 07, 2012 |
not rated yet |
0
Combination of oral drugs suppresses common type of hepatitis C
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Jan 19, 2012 |
not rated yet |
0
|
New fibrosis classification improves accuracy of diagnosis in hepatitis C
A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study appearing in the January ...
Jan 10, 2012 |
not rated yet |
0
High rates of disability and health care use for older Americans with cirrhosis
New research shows that older Americans with cirrhosis have significantly worse health status and greater functional disability compared to those without this potentially deadly disease. In fact, findings now published in ...
Jan 10, 2012 |
not rated yet |
0
Studies identify risk factors in rising trend of liver cancer
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Pr ...
Jan 03, 2012 |
4 / 5 (1) |
0
Obesity and diabetes epidemics spur increase in nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity ...
Dec 14, 2011 |
not rated yet |
0
Boceprevir: Indication of added benefit for specific patients
The active ingredient boceprevir has been available since the middle of 2011 as a treatment for chronic hepatitis C of genotype 1. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal ...
Dec 09, 2011 |
not rated yet |
0
Manipulating serotonin can promote healthy repair in chronic liver disease
(Medical Xpress) -- Publishing in the leading medical journal Nature Medicine, a team led by Newcastle University academics have identified serotonin receptors which can be targeted with drugs to enhance the natural healin ...
Nov 28, 2011 |
5 / 5 (5) |
1
|
Scientists make human blood protein from rice
Scientists at a Chinese university said Monday they can use rice to make albumin, a protein found in human blood that is often used for treating burns, traumatic shock and liver disease.
Oct 31, 2011 |
4.6 / 5 (7) |
0
CDC: Add $2 per drink for US excessive drinking
(AP) -- The toll of excessive drinking works out to about $2 per drink, in terms of medical expenses and other costs to society, according to a new federal research.
Oct 17, 2011 |
5 / 5 (1) |
11
New gene therapy methods accurately correct mutation in patient's stem cells
For the first time, scientists have cleanly corrected a human gene mutation in a patient's stem cells. The result, reported in Nature on Wednesday 12 October, brings the possibility of patient-specific therapies closer to bec ...
Oct 12, 2011 |
4.6 / 5 (10) |
0
|
Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C
Patients with non-alcoholic fatty liver disease (NAFLD) with advanced fibrosis or cirrhosis have a lower incidence of liver-related complications and hepatocellular carcinoma (HCC) than patients infected with hepatitis C ...
Sep 27, 2011 |
not rated yet |
0
Study suggests obesity accelerates progression of cirrhosis
Researchers from the United States and Europe involved in an NIH-funded multicenter study have determined that increased body mass index (BMI) is an independent predictor of clinical decompensation in patients with compensated ...
Jul 21, 2011 |
not rated yet |
0
Pinpointing a tell-tale mark of liver cancer
Persistent hepatitis C virus (HCV) infection can lead to chronic hepatitis C and then progress to fatal liver diseases including liver cirrhosis and liver cancer, the third most common cause of cancer-related ...
Jul 08, 2011 |
not rated yet |
0
|
Overweight more harmful to the liver than alcohol in middle-aged men
Overweight carries a greatly increased risk of cirrhosis of the liver in men, reveals a new study from the Sahlgrenska Academy. "Given the increasing problem of overweight in Sweden, there is reason to fear that more people ...
Jun 07, 2011 |
not rated yet |
0
Cirrhosis
Cirrhosis is a consequence of chronic liver disease characterized by replacement of liver tissue by fibrous scar tissue as well as regenerative nodules (lumps that occur as a result of a process in which damaged tissue is regenerated), leading to progressive loss of liver function. Cirrhosis is most commonly caused by alcoholism, hepatitis B and C, and fatty liver disease but has many other possible causes. Some cases are idiopathic, i.e., of unknown cause.
Ascites (fluid retention in the abdominal cavity) is the most common complication of cirrhosis and is associated with a poor quality of life, increased risk of infection, and a poor long-term outcome. Other potentially life-threatening complications are hepatic encephalopathy (confusion and coma) and bleeding from esophageal varices. Cirrhosis is generally irreversible once it occurs, and treatment generally focuses on preventing progression and complications. In advanced stages of cirrhosis the only option is a liver transplant.
The word "cirrhosis" derives from Greek κίρῥος, meaning tawny (the orange-yellow colour of the diseased liver). While the clinical entity was known before, it was René Laennec who gave it the name "cirrhosis" in his 1819 work in which he also describes the stethoscope.
For more information about Cirrhosis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
